Related references
Note: Only part of the references are listed.Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort
T. Kalincik et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2012)
Corpus Callosum Atrophy - A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study
M. Vaneckova et al.
EUROPEAN NEUROLOGY (2012)
Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis
Veronika Ticha et al.
NEUROLOGICAL RESEARCH (2012)
Genotype-phenotype correlation for non-HLA disease associated risk alleles in multiple sclerosis
Katharine Harding et al.
NEUROSCIENCE LETTERS (2012)
Multiple Sclerosis Risk Variant HLA-DRB1*1501 Associates with High Expression of DRB1 Gene in Different Human Populations
Antonio Alcina et al.
PLOS ONE (2012)
Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study
Tomas Kalincik et al.
PLOS ONE (2012)
Genome-wide association study of severity in multiple sclerosis
Farren B. S. Briggs et al.
GENES AND IMMUNITY (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data
Joanne H. Wang et al.
GENOME MEDICINE (2011)
IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci
F. Esposito et al.
GENES AND IMMUNITY (2010)
Intermediate Phenotypes Identify Divergent Pathways to Alzheimer's Disease
Joshua M. Shulman et al.
PLOS ONE (2010)
Multiple Sclerosis Susceptibility-Associated SNPs Do Not Influence Disease Severity Measures in a Cohort of Australian MS Patients
Cathy J. Jensen et al.
PLOS ONE (2010)
A Putative Alzheimer's Disease Risk Allele in PCK1 Influences Brain Atrophy in Multiple Sclerosis
Zongqi Xia et al.
PLOS ONE (2010)
GenotypePhenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by (HMR)-H-1 spectroscopy and MRI measures
D. T. Okuda et al.
BRAIN (2009)
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
Sergio E. Baranzini et al.
HUMAN MOLECULAR GENETICS (2009)
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Bruce D. Trapp et al.
LANCET NEUROLOGY (2009)
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score
Philip L. De Jager et al.
LANCET NEUROLOGY (2009)
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
Philip L. De Jager et al.
NATURE GENETICS (2009)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The impact of HLA-A and-DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients
C. Smestad et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial
M Filippi et al.
LANCET (2004)
HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course
LF Barcellos et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Accurate, robust, and automated longitudinal and cross-sectional brain change analysis
SM Smith et al.
NEUROIMAGE (2002)
HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis
AE Hensiek et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
HLA-DRB1 and disease outcome in multiple sclerosis
SJM Weatherby et al.
JOURNAL OF NEUROLOGY (2001)
Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis
EG Celius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS
SL Hauser et al.
NEUROLOGY (2000)
Share Paper
